Mayo Clinic
The purpose of this study is to better understand the effects of nicotinamide riboside supplement in overall cardiovascular health in healthy adults.
This study is a randomized, double-blind, placebo-controlled, parallel-dose clinical trial. Participants will be randomly assigned to one of three groups. Study measurements will be completed at three timepoints and intervention taken daily throughout the subject's 12 weeks of participation.
Inclusion Criteria: * \>= 35 and \<=70 * Provides consent to participate in the study * Not pregnant at time of consent * Understands and agrees to follow all study procedures and limitations * Have no contraindicating comorbid health condition as determined by the clinical investigators Exclusion Criteria: * Pregnant, nursing, or trying to conceive * BMI Restrictions: \<35 * Allergy or sensitivity to study agent ingredients * Hypertension treated with medication * Use of natural health products containing nicotinamide riboside, quercetin, trans-resveratrol, or betaine anhydrous within 7 da…
Active supplement.
Placebo
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.